CD44 and prostate carcinoma: Additionally, ALDHhi CD44+α2β1+ cells increased with castration resistance in mice implanted with prostate cancer cell line xenografts and, when isolated from patients, displayed potential self-renewal capacity based on colony and spheroid formation [30].